|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalent | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Prepaid license fees - current | ||||||||||||||||||||
| Equity receivable | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Prepaid license fees – long term | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Capitalized software development, net of accumulated amortization | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable - related party | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Stock repurchase liability | ||||||||||||||||||||
| Convertible note payable and accrued interest, net of discount of $428 and $0, respectively | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Notes payable related parties | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Notes payable – related party | ||||||||||||||||||||
| Convertible notes payable, net of discount of $326 and $66, respectively | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Right of use liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable – related party, net of current portion | ||||||||||||||||||||
| Notes payable, net of current portion | ||||||||||||||||||||
| Right of use liability, net of current portion | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Series A preferred stock; $0.001 par value; 100,000 shares authorized; 14 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.001 par value; 105,263,158 shares authorized; 42,003,934 and 40,488,934 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
Loading...
